Purchase Order FA442724P0135
Award Date
9/27/24
Potential Completion Date
9/26/25
Potential Value
$706K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Air Mobility Command
Awardee
Abbott Laboratories Inc.
Ultimate Awardee
Abbott Laboratories Inc.
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6630 - Chemical Analysis Instruments
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Travis AFB, Fairfield, CA, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a negotiated order against an ordering vehicle for a chemical analyzer, with a ceiling value of $934,615.23. The contract was awarded to Abbott Laboratories Inc., a global healthcare company that specializes in medical devices, diagnostic products, and laboratory equipment. The contract is a firm fixed-price delivery order, with an ultimate completion date of December 19, 2026. The funding agency is the Defense Health Agency, a defense agency that provides...
This is a $5,605,749.60 firm fixed-price delivery order awarded to Abbott Laboratories Inc. under the Defense Health Agency's General Services Administration Federal Supply Schedule contract for Critical Analyzers, Laboratory (FSS-66-III). The award is for FY 2024 Chemistry Immunology Contract Performance Requirement Review (CPRR) services, with a period of performance through September 2027. The contract does not have a set-aside designation. Abbott Laboratories, a major manufacturer of medical...
The U.S. Department of the Army Medical Command has awarded a 6-month delivery order contract to Abbott Laboratories Inc., through its Abbott Diagnostics Division, for the purchase of an Abbott chemistry analyzer. The $118,760.34 firm fixed price contract has a completion date of September 19, 2022 and is being issued under Abbott's existing General Services Administration (GSA) Federal Supply Schedule contract for Critical Analyzers, Laboratory (FSS-66-III). No set-aside designation was used...
This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Abbott Laboratories Inc., a global healthcare company, for the provision of an "Automated Core Lab" solution. The contract has a ceiling value of $26,000.00 and a period of performance through April 30, 2025. It was awarded on April 1, 2025, and does not have a set-aside designation. The contract is likely part of the Defense Health Agency's broader efforts to support medical testing capabilities...
This is a delivery order issued under the General Services Administration (GSA) Federal Supply Schedule for Critical Analyzers, Laboratory (FSS-66-III). The U.S. Department of Defense (DOD) Medical Command (MEDCOM) awarded a $535,432.75 firm-fixed-price contract to Abbott Laboratories Inc., through its Abbott Diagnostics Division, for in vitro reagents for pathology testing equipment. The award has no set-aside designation. Abbott Laboratories is a global healthcare company that provides a...
This is a federal contract award to Abbott Laboratories Inc. by the Department of the Army Medical Command for the provision of clinical chemistry and immunoassay supplies. The contract is a Delivery Order issued under Abbott's existing General Services Administration (GSA) Federal Supply Schedule contract for Critical Analyzers, Laboratory. The contract has a potential value of $2,511,922.58 and a completion date of October 31, 2021. No set-aside designation is specified. As a major...
The Department of the Army Medical Command awarded Abbott Laboratories Inc., a health care company, a firm fixed price purchase order for $449,961.98 to provide clinical chemistry and immunoassay testing services, automated analyzers, reagents, test kits, and associated equipment and consumables. This award is not associated with a set-aside program. Abbott Laboratories Inc., through its Abbott Diagnostics Division, has provided a wide variety of goods and services to federal agencies...
This federal contract award, valued at $3,795.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a global healthcare company. The award is a delivery order contract with a fixed price and economic price adjustment pricing type. The contract supports the delivery of medical diagnostic equipment, including blood analyzers, COVID-19 testing supplies, chemistry and immunochemistry testing instruments, reagents, and consumables. This...
This is a firm fixed-price delivery order award by the Defense Health Agency to Abbott Laboratories Inc., a global healthcare company, under the GSA Federal Supply Schedule contract for Critical Analyzers, Laboratory (FSS-66-III). The $1,782,460.00 contract is for the provision of clinical chemistry and immunoassay testing equipment, reagents, and associated services. The award supports the agency's medical diagnostic testing requirements, including for infectious diseases, COVID-19, and...
This federal contract award, valued at $165,000.00, was issued by the Defense Health Agency to Abbott Laboratories Inc. as a Blanket Purchase Agreement (BPA) Call for clinical chemistry and immunoassay tests. The award supports the provision of these diagnostic services from May 1, 2024 through May 31, 2024. Abbott Laboratories Inc., a large pharmaceutical and medical device company, is providing these products and services through its Abbott Diagnostics Division. The contract does not have a...